Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover.
D000818:Animals; D001921:Brain / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D002247:Carbon Isotopes; D005664:Furazolidone / Q000494:pharmacology; D006207:Half-Life; D006834:Hydrazines / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000166:cytology / Q000201:enzymology; D007421:Intestine, Small; D007930:Leucine; D008099:Liver / Q000166:cytology / Q000201:enzymology / Q000378:metabolism; D008297:Male; D008928:Mitochondria / Q000201:enzymology*; D008930:Mitochondria, Liver / Q000201:enzymology; D008995:Monoamine Oxidase / Q000096:biosynthesis / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology
D002247:Carbon Isotopes; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011506:Proteins; D014191:Tranylcypromine; D005664:Furazolidone; D010293:Pargyline; D008995:Monoamine Oxidase; D007930:Leucine